InnFocus closes Series C financing with $33.9M for glaucoma device
InnFocus has raised funds to further develop its InnFocus MicroShunt glaucoma drainage system to treat early, moderate, and late stage primary open angle glaucoma.
InnFocus has raised funds to further develop its InnFocus MicroShunt glaucoma drainage system to treat early, moderate, and late stage primary open angle glaucoma.